Pictet Health Inclusive - Class P - Income (GBP)

Lydia Haueter joined Pictet Asset Management in 2016 and is an Investment Manager in the Thematic Equities team. Lydia began her career in 2011 at Bellevue Asset Management as an analyst covering biotech stocks; there she became an investment manager (small-mid cap biotech). Lydia graduated with a Master of Science in Systems Biology from ETH Zürich and she is Chartered Financial Analyst (CFA) charterholder.

Moritz Dullinger joined Pictet Asset Management in 2018 as a Senior Investment Manager for Pictet-Health within the Thematic Equities team. Before joining Pictet, Moritz was responsible for the RobecoSAM ?Healthy Living? equity fund. Prior to this, he was a project manager responsible for strategic healthcare investments at a portfolio company of the Carlyle Group. He started his career as a sell side equity research analyst at Kepler Cheuvreux covering European healthcare stocks. Moritz holds a Bachelor's in Economics from the University of Hagen. He is also a Chartered Financial Analyst (CFA) and Chartered Alternative Investment Analyst (CAIA) charterholder.

Tazio Storni joined Pictet Asset Management in October 2014 as a Senior Investment Manager in the Sector & Theme Funds team. He began his investment career in 2005 with UBS Global Asset Management, as a financial analyst covering Biotech, Medtech and Chemical companies. In 2010 he took over the responsibility for the UBS (Lux) Equity Health Care fund. Prior to joining Pictet Asset Management Tazio worked for Bellevue Asset Management as lead portfolio manager on the BB Biotech (Lux) Fund. He holds a Masters in Biology and a PhD in Immunology from the Eidgenössische Technishe Horchschule in Zurich (ETH). Tazio is a Chartered Financial Analyst (CFA) charterholder.

Grégoire Biollaz joined Pictet Asset Management in 2016 and is a Senior Investment Manager in the Thematic Equities team focusing on Health and Biotech strategies. Prior to joining Pictet, Grégoire was a Senior Equity Analyst at the family office aeris Capital, responsible for the global Healthcare sector. Before this he worked at Credit Suisse as a buy-side Senior Equity Analyst covering the global Healthcare and Chemicals sectors. Prior to entering the financial industry, Grégoire worked as a Research Scientist at Immunex, at that time one the world's fastest growing biotech companies, now part of Amgen. Grégoire holds a PhD in Biochemistry and a Master of Science in Biology, both from Eidgenössische Technische Horchschule in Zurich (ETH).